Biodesix Inc. executed a one-for-twenty reverse stock split effective September 15, 2025, following stockholder approval on May 20, 2025. Additionally, on September 12, 2025, the company filed to eliminate provisions for the Series A Non-Voting Convertible Preferred Stock.